Recurrent Episodes with Serous Retinal Detachment and Anterior Uveitis in a Patient Using Nivolumab (Anti -PD-1 Antibody) Therapy: A case report and literature review


YILMAZ TUĞAN B., ÖZKAN B., SÖNMEZ Ö.

SEMINARS IN OPHTHALMOLOGY, vol.36, no.8, pp.794-799, 2021 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 36 Issue: 8
  • Publication Date: 2021
  • Doi Number: 10.1080/08820538.2021.1906916
  • Journal Name: SEMINARS IN OPHTHALMOLOGY
  • Journal Indexes: Science Citation Index Expanded
  • Page Numbers: pp.794-799
  • Keywords: Metastatic malignant melanoma, nivolumab, serous retinal detachment, anterior uveitis, anti-PD-1 antibody

Abstract

Aim: Nivolumab is an immune checkpoint inhibitor that has recently been widely used for metastatic malignant melanoma. We report a case who developed multiple different ocular immune-related side effects (iRAEs) related to nivolumab.